The FDA recently approved the first continuous glucose monitoring system able to substitute for traditional fingerstick blood glucose (sugar) testing in diabetic patients over age 2, from Silver Spring, Maryland.
Purdue Pharma and Exicure Inc. have entered into a strategic research partnership, option and license agreement in order to determine and develop treatments for psoriasis and other diseases amenable to a gene regulation approach.
Global biopharmaceutical company Sucampo Pharmaceuticals intends to offer qualified institutional buyers convertible senior notes in the total amount of $225 million principle, subject to market and other conditions.
Eisai Inc. and Arena Pharmaceutical recently announced that Belviq, developed by Eisai subsidiary Eisai Laboratories, has been given regulatory approval by the Brazilian Health Surveillance Agency (ANVISA).
The recent passage of the multibillion-dollar 21st Century Cures Act, lauded for funding and accelerating medical research, may not go far enough, according to a senior researcher at George Mason University in Virginia.
A study published today in the journal Nature Communications on the immune system pathways key to developing a better tuberculosis vaccine is supported by the National Institute of Allergy and Infectious Diseases.